Weiss Multi Strategy Advisers LLC Reata Pharmaceuticals Inc Transaction History

Weiss Multi Strategy Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $247,600 - $354,117	-2,476 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $21,602 - $41,756	-276 Reduced 10.03%	2,476 $350,000
Q1 2021 May 14, 2021	SELL	$94.25 - $132.81 $10,744 - $15,140	-114 Reduced 3.98%	2,752 $274,000
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $1.54 Million - $2.79 Million	-15,134 Reduced 84.08%	2,866 $354,000
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $284,892 - $497,533	3,046 Added 20.37%	18,000 $1.75 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $68,454 - $95,695	542 Added 3.76%	14,954 $2.33 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $512,035 - $1.02 Million	4,124 Added 40.09%	14,412 $2.08 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $543,466 - $1.59 Million	7,288 Added 242.93%	10,288 $2.1 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $213,780 - $287,250	3,000 New	3,000 $241,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.